Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-21-Speech-2-519"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20100921.18.2-519"2
lpv:hasSubsequent
lpv:speaker
lpv:spoken text
"Improvements to the current system of pharmacovigilance are necessary to have a system which operates quickly and efficiently in order to better protect consumers. The monitoring of the safety of medicines can be crucial to save lives and prevent public health crises. Further integration of pharmacovigilance at the European level is necessary because it increases the number of consumers reporting incidents of adverse drug reactions (ADRs). By increasing the pool of reported ADRs patterns, they can be assessed more quickly, thus allowing for drugs with adverse side effects to be withdrawn from the market or warnings added to the medicines. I support the amendments that seek to further protect consumers by allowing public and healthcare professionals full access to the central European EudraVigilance database. This allows all Member States to have access to the same information regarding ADRs. I agree to exclude pharmaceutical companies from the process of pharmacovigilance. In view of the facts, taking the pharmaceutical companies out of the process allows for more honest reporting of ADRs by removing the conflict of interest inherent in the process of self regulation."@en1
lpv:spokenAs
lpv:unclassifiedMetadata

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph